Vaccine Bioprocess Development and Commercialisation
UCL Bloomsbury Campus
18 - 20 June 2024
£1750 Special prices for group packages and SMEs available.
Delivered in collaboration with Massachusetts Institute of Technology (MIT), this course will a
ssist in developing your knowledge on the challenges of creating a vaccine process.
The course is designed to explore the critical issues at each stage of vaccine development. Attendees hear from international experts about the research as well as operational and regulatory challenges facing the global vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about strategies for commercial specifications for vaccines.
Topics covered will include:
Introduction to Vaccine Development with Case Studies
Scale-up from lab to pilot scale
Quality by Design (QbD) as part of vaccine development
Expression systems
Single use platforms
Process Development Challenges of Novel Vaccines
Adventitious Agent Contamination in Biomanufacturing
Final formulation and adjuvants
Regulatory Perspectives and Future Directions
Global Vaccine Preparedness to Respond to Future Disease Outbreaks
This course is of interest to research scientists, programme managers, process engineers and policy makers. The course is accessible to those new to vaccine development or those working in the field from business and academia.